BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29938829)

  • 1. MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
    Li J; Smith AR; Marquez RT; Li J; Li K; Lan L; Wu X; Zhao L; Ren F; Wang Y; Wang Y; Jia B; Xu L; Chang Z
    Mol Carcinog; 2018 Oct; 57(10):1408-1420. PubMed ID: 29938829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
    Zhang Z; Shao L; Wang Y; Luo X
    Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
    Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
    Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of CREPT promotes tumor growth and is correlated with poor prognosis in colorectal cancer.
    Zheng G; Li W; Zuo B; Guo Z; Xi W; Wei M; Chen P; Wen W; Yang AG
    Biochem Biophys Res Commun; 2016 Nov; 480(3):436-442. PubMed ID: 27773816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer.
    Ding L; Yang L; He Y; Zhu B; Ren F; Fan X; Wang Y; Li M; Li J; Kuang Y; Liu S; Zhai W; Ma D; Ju Y; Liu Q; Jia B; Sheng J; Chang Z
    Cell Death Dis; 2018 Dec; 9(12):1172. PubMed ID: 30518842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREPT regulated by miR-138 promotes breast cancer progression.
    Liang Z; Feng Q; Xu L; Li S; Zhou L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):263-269. PubMed ID: 28893536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
    Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
    J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
    Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
    Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
    Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
    Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-23a promotes colorectal cancer cell migration and proliferation by targeting at MARK1.
    Tang X; Yang M; Wang Z; Wu X; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):661-668. PubMed ID: 31281935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
    Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW
    Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.
    Jin Y; Cheng H; Cao J; Shen W
    J Cell Biochem; 2019 Nov; 120(11):18629-18639. PubMed ID: 31338872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner.
    Zhai W; Ye X; Wang Y; Feng Y; Wang Y; Lin Y; Ding L; Yang L; Wang X; Kuang Y; Fu X; Eugene Chin Y; Jia B; Zhu B; Ren F; Chang Z
    Br J Cancer; 2021 Apr; 124(8):1437-1448. PubMed ID: 33531691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
    Wu W; Wang Z; Yang P; Yang J; Liang J; Chen Y; Wang H; Wei G; Ye S; Zhou Y
    Mol Cell Biochem; 2014 Mar; 388(1-2):249-59. PubMed ID: 24343340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-8073: Tumor suppressor and potential therapeutic treatment.
    Mizoguchi A; Takayama A; Arai T; Kawauchi J; Sudo H
    PLoS One; 2018; 13(12):e0209750. PubMed ID: 30589909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREPT promotes glioma cell proliferation and invasion by activating Wnt/β-catenin pathway and is a novel target of microRNA-596.
    Wei M; Cao Y; Jia D; Zhao H; Zhang L
    Biochimie; 2019 Jul; 162():116-124. PubMed ID: 30995540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
    Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
    Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.